<h2 id="Headline">
 Headline
</h2>
<h3 id="PCK1_vacillating_between_gluconeogenesis_and_lipogenesis">
 PCK1 vacillating between gluconeogenesis and lipogenesis
</h3>
<p>
 Lipid metabolism is a tightly regulated process, which relies on sterol regulatory element-binding (SREBPs) transcription factors for the activation of genes involved in the synthesis of fatty acids, triglycerides, and cholesterol. In resting conditions, when the levels of cholesterol are sufficient, SREBPs are present as precursors in the endoplasmic reticulum (ER) membrane in complex with a protein called SCAP. SCAP also interacts with a member of the ER resident INSIG protein family. The interaction with INSIG ensures that the SCAP-SREBP complex is retained in the ER. When cholesterol levels drop, INSIG and SCAP no longer bind and the SCAP-SREBP complex is
 <a href="https://en.wikipedia.org/wiki/Sterol%5Fregulatory%5Felement-binding%5Fprotein#/media/File:SREBP%5Fregulatory%5Fmechanism.png">
  transported to the Golgi apparatus
 </a>
 , where SREBP is cleaved and its cytosolic N-terminal transcription factor domain is freed to translocate to the nucleus and activate transcription.
</p>
<p>
 There are cells, however, that do not bother about regulation and just desperately need lipogenesis to proliferate. These are cancer cells. How do they achieve the synthesis of enough lipids in normal sterol levels, in conditions in which lipogenesis would normally be inhibited? The answer came from
 <a href="https://pubmed.ncbi.nlm.nih.gov/32322062/">
  a study in hepatocellular carcinoma (HCC) cell lines
 </a>
 . In these cells, activation with IGF1, a stimulus critical for HCC development, leads to a cascade of phosphorylation, which starts with AKT1. Activated AKT1 in turn phosphorylates PCK1, which is then translocated from the cytosol to the ER and phosphorylates INSIG. This impairs INSIG binding to the SCAP-SREBP complex, resulting in the release of the complex from the ER to the Golgi apparatus, with subsequent SERBP activation.
</p>
<p>
 The discovery of PCK1 involvement in this process comes as a surprise. PCK1 is not known to be involved in lipogenesis regulation, nor to have a kinase activity. It is a rate-limiting enzyme of gluconeogenesis, a pathway that generates glucose from certain non-carbohydrate carbon substrates. In this pathway, it converts oxaloacetate into phosphoenolpyruvate. PCK1 phosphorylation by AKT1 uncovers its cryptic kinase activity and redirects it to a completely different process. Cancer cells favor glycolysis to provide energy and metabolic intermediates, and suppress gluconeogenesis. For these cells, PCK1 diversion is necessary for cell growth, as expression of a PCK1 nonphosphorylatable mutant inhibits cell proliferation, and is costless, as inhibition of gluconeogenesis is not deleterious. Although the results have been produced in HCC cells, this process may also play a role in other cancer types. Indeed, AKT1 activation has been shown in melanoma, glioblastoma and non-small cell lung carcinoma cells.
</p>
<p>
 PCK1-induced activation of SREBP1 may also occur in normal hepatocytes. In mice that were refed with glucose after 24 hours of fasting, phosphorylation of AKT1, PCK1, and INSIG proteins, as well as cleavage of SREBP1, were markedly enhanced in normal liver. These observations suggest that in vivo blood glucose levels may regulate the PCK1-mediated phosphorylation of INSIG proteins and the activation of SREBP. This might point toward a potential mechanism underlying overnutrition-promoted nonalcoholic fatty liver diseases.
</p>
<p>
 As of this release,
 <a href="http://www.uniprot.org/uniprot/?query=32322062">
  proteins involved in this new regulatory pathway
 </a>
 have been updated and are available in UniProtKB/Swiss-Prot.
</p>
<h2 id="UniProtKB_news">
 UniProtKB news
</h2>
<h3 id="Cross_references_to_CPTC">
 Cross-references to CPTC
</h3>
<p>
 Cross-references have been added to CPTC, the CPTAC Antibody Portal. This portal serves as a National Cancer Institute (NCI) community resource that provides access to a large number of standardized renewable affinity reagents (to cancer-associated targets) and accompanying characterization data.
</p>
<p>
 CPTC is available at
 <a href="https://proteomics.cancer.gov/antibody-portal">
  https://proteomics.cancer.gov/antibody-portal
 </a>
 .
</p>
<p>
 The format of the explicit links is:
</p>
<table>
 <tr>
  <th>
   Resource abbreviation
  </th>
  <td>
   CPTC
  </td>
 </tr>
 <tr>
  <th>
   Resource identifier
  </th>
  <td>
   UniProtKB accession number
  </td>
 </tr>
 <tr>
  <th>
   Optional information 1
  </th>
  <td>
   Number of antibodies
  </td>
 </tr>
</table>
<p>
 Example:
 <a href="http://www.uniprot.org/uniprot/P31751">
  P31751
 </a>
</p>
<p>
 <a href="http://www.uniprot.org/uniprot/?query=database:cptc&amp;sort=score">
  Show all entries having a cross-reference to CPTC.
 </a>
</p>
<h4 id="Text_format">
 Text format
</h4>
<p>
 Example:
 <a href="http://www.uniprot.org/uniprot/P31751.txt">
  P31751
 </a>
</p>
<pre>DR   CPTC; P31751; 6 antibodies.
</pre>
<h4 id="XML_format">
 XML format
</h4>
<p>
 Example:
 <a href="http://www.uniprot.org/uniprot/P31751.xml">
  P31751
 </a>
</p>
<pre>&lt;dbReference type="CPTC" id="P31751"&gt;
  &lt;property type="antibodies" value="6 antibodies"/&gt;
&lt;/dbReference&gt;
</pre>
<h4 id="RDF_format">
 RDF format
</h4>
<p>
 Example:
 <a href="http://www.uniprot.org/uniprot/P31751.ttl">
  P31751
 </a>
</p>
<pre>uniprot:P31751
  rdfs:seeAlso &lt;http://purl.uniprot.org/cptc/P31751&gt; .
&lt;http://purl.uniprot.org/cptc/P31751&gt;
  rdf:type up:Resource ;
  up:database &lt;http://purl.uniprot.org/database/CPTC&gt; ;
  rdfs:comment "6 antibodies" .
</pre>
<h3 id="Cross_references_to_BMRB">
 Cross-references to BMRB
</h3>
<p>
 Cross-references have been added to the BMRB database, the Biological Magnetic Resonance Data Bank. BMRB collects, annotates, archives, and disseminates spectral and quantitative data derived from NMR spectroscopic investigations of biological macromolecules and metabolites.
</p>
<p>
 BMRB is available at
 <a href="https://bmrb.io/">
  https://bmrb.io/
 </a>
 .
</p>
<p>
 The format of the explicit links is:
</p>
<table>
 <tr>
  <th>
   Resource abbreviation
  </th>
  <td>
   BMRB
  </td>
 </tr>
 <tr>
  <th>
   Resource identifier
  </th>
  <td>
   UniProtKB accession number
  </td>
 </tr>
</table>
<p>
 Example:
 <a href="http://www.uniprot.org/uniprot/A1D240">
  A1D240
 </a>
</p>
<p>
 <a href="http://www.uniprot.org/uniprot/?query=database:bmrb&amp;sort=score">
  Show all entries having a cross-reference to BMRB.
 </a>
</p>
<h4 id="Text_format">
 Text format
</h4>
<p>
 Example:
 <a href="http://www.uniprot.org/uniprot/A1D240.txt">
  A1D240
 </a>
</p>
<pre>DR   BMRB; A1D240; -.
</pre>
<h4 id="XML_format">
 XML format
</h4>
<p>
 Example:
 <a href="http://www.uniprot.org/uniprot/A1D240.xml">
  A1D240
 </a>
</p>
<pre>&lt;dbReference type="BMRB" id="A1D240"/&gt;
</pre>
<h4 id="RDF_format">
 RDF format
</h4>
<p>
 Example:
 <a href="http://www.uniprot.org/uniprot/A1D240.ttl">
  A1D240
 </a>
</p>
<pre>uniprot:A1D240
  rdfs:seeAlso &lt;http://purl.uniprot.org/bmrb/A1D240&gt; .
&lt;http://purl.uniprot.org/bmrb/A1D240&gt;
  rdf:type up:Resource ;
  up:database &lt;http://purl.uniprot.org/database/BMRB&gt; .
</pre>
<h3 id="Cross_references_to_PCDDB">
 Cross-references to PCDDB
</h3>
<p>
 Cross-references have been added to the PCDDB database, the Protein Circular Dichroism Data Bank. PCDDB is a public repository that archives and freely distributes circular dichroism (CD) and synchrotron radiation CD spectral data and their associated experimental metadata.
</p>
<p>
 PCDDB is available at
 <a href="https://pcddb.cryst.bbk.ac.uk/">
  https://pcddb.cryst.bbk.ac.uk/
 </a>
 .
</p>
<p>
 The format of the explicit links is:
</p>
<table>
 <tr>
  <th>
   Resource abbreviation
  </th>
  <td>
   PCDDB
  </td>
 </tr>
 <tr>
  <th>
   Resource identifier
  </th>
  <td>
   UniProtKB accession number
  </td>
 </tr>
</table>
<p>
 Example:
 <a href="http://www.uniprot.org/uniprot/Q70Q12">
  Q70Q12
 </a>
</p>
<p>
 <a href="http://www.uniprot.org/uniprot/?query=database:pcddb&amp;sort=score">
  Show all entries having a cross-reference to PCDDB.
 </a>
</p>
<h4 id="Text_format">
 Text format
</h4>
<p>
 Example:
 <a href="http://www.uniprot.org/uniprot/Q70Q12.txt">
  Q70Q12
 </a>
</p>
<pre>DR   PCDDB; Q70Q12; -.
</pre>
<h4 id="XML_format">
 XML format
</h4>
<p>
 Example:
 <a href="http://www.uniprot.org/uniprot/Q70Q12.xml">
  Q70Q12
 </a>
</p>
<pre>&lt;dbReference type="PCDDB" id="Q70Q12"/&gt;
</pre>
<h4 id="RDF_format">
 RDF format
</h4>
<p>
 Example:
 <a href="http://www.uniprot.org/uniprot/Q70Q12.ttl">
  Q70Q12
 </a>
</p>
<pre>uniprot:Q70Q12
  rdfs:seeAlso &lt;http://purl.uniprot.org/pcddb/Q70Q12&gt; .
&lt;http://purl.uniprot.org/pcddb/Q70Q12&gt;
  rdf:type up:Resource ;
  up:database &lt;http://purl.uniprot.org/database/PCDDB&gt; .
</pre>
<h3 id="Cross_references_to_SASBDB">
 Cross-references to SASBDB
</h3>
<p>
 Cross-references have been added to the SASBDB database, the Small Angle Scattering Biological Data Bank. SASBDB is a fully searchable curated repository of freely accessible and downloadable experimental scattering data, which are deposited together with the relevant experimental conditions, sample details, derived models and their fits to the data.
</p>
<p>
 SASBDB is available at
 <a href="https://www.sasbdb.org/">
  https://www.sasbdb.org/
 </a>
 .
</p>
<p>
 The format of the explicit links is:
</p>
<table>
 <tr>
  <th>
   Resource abbreviation
  </th>
  <td>
   SASBDB
  </td>
 </tr>
 <tr>
  <th>
   Resource identifier
  </th>
  <td>
   UniProtKB accession number
  </td>
 </tr>
</table>
<p>
 Example:
 <a href="http://www.uniprot.org/uniprot/Q15326">
  Q15326
 </a>
</p>
<p>
 <a href="http://www.uniprot.org/uniprot/?query=database:sasbdb&amp;sort=score">
  Show all entries having a cross-reference to SASBDB.
 </a>
</p>
<h4 id="Text_format">
 Text format
</h4>
<p>
 Example:
 <a href="http://www.uniprot.org/uniprot/Q15326.txt">
  Q15326
 </a>
</p>
<pre>DR   SASBDB; Q15326; -.
</pre>
<h4 id="XML_format">
 XML format
</h4>
<p>
 Example:
 <a href="http://www.uniprot.org/uniprot/Q15326.xml">
  Q15326
 </a>
</p>
<pre>&lt;dbReference type="SASBDB" id="Q15326"/&gt;
</pre>
<h4 id="RDF_format">
 RDF format
</h4>
<p>
 Example:
 <a href="http://www.uniprot.org/uniprot/Q15326.ttl">
  Q15326
 </a>
</p>
<pre>uniprot:Q15326
  rdfs:seeAlso &lt;http://purl.uniprot.org/sasbdb/Q15326&gt; .
&lt;http://purl.uniprot.org/sasbdb/Q15326&gt;
  rdf:type up:Resource ;
  up:database &lt;http://purl.uniprot.org/database/SASBDB&gt; .
</pre>
<h3 id="Changes_to_the__a_href___docs_humdisease__controlled_vocabulary_of_human_diseases__a_">
 Changes to the
 <a href="http://www.uniprot.org/docs/humdisease">
  controlled vocabulary of human diseases
 </a>
</h3>
<p>
 New diseases:
</p>
<ul>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05853">
   46,XX sex reversal 5
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05864">
   Agenesis of corpus callosum, cardiac, ocular, and genital syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05863">
   Arrhythmogenic right ventricular dysplasia, familial, 14
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05821">
   Autism 20
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05822">
   Combined oxidative phosphorylation deficiency 44
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05843">
   Congenital disorder of glycosylation 2T
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05859">
   Deafness, autosomal dominant, 77
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05823">
   Diabetes mellitus, permanent neonatal 2
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05824">
   Diabetes mellitus, permanent neonatal 3
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05825">
   Diabetes mellitus, permanent neonatal 4
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05834">
   Epilepsy, progressive myoclonic 11
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05854">
   Epileptic encephalopathy, early infantile, 86
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05860">
   Epileptic encephalopathy, early infantile, 87
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05857">
   Fanconi renotubular syndrome 1
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05856">
   Fanconi renotubular syndrome 5
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05839">
   Galactosemia 4
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05838">
   Glaucoma, primary closed-angle
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05848">
   Harderoporphyria
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05866">
   Hao-Fountain syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05841">
   Hypoparathyroidism, familial isolated, 2
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05840">
   Imerslund-Grasbeck syndrome 2
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05852">
   Intellectual developmental disorder with autistic features and language delay, with or without seizures
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05835">
   Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05836">
   Leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05845">
   Liberfarb syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05832">
   Lissencephaly 10
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05847">
   Microcephaly, developmental delay, and brittle hair syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05829">
   Neurodegeneration, childhood-onset, with ataxia, tremor, optic atrophy, and cognitive decline
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05858">
   Neurodevelopmental, jaw, eye, and digital syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05846">
   Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05827">
   Neurodevelopmental disorder with hypotonia, microcephaly, and seizures
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05837">
   Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05861">
   Neurodevelopmental disorder with language impairment and behavioral abnormalities
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05826">
   Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05831">
   Nizon-Isidor syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05862">
   Periventricular nodular heterotopia 9
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05842">
   Proteinuria, chronic benign
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05844">
   Pseudo-TORCH syndrome 3
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05865">
   Pyrin-associated autoinflammatory disease
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05849">
   Radioulnar synostosis, non-syndromic
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05833">
   Seizures, early-onset, with neurodegeneration and brain calcification
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05850">
   Silver-Russell syndrome 4
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05851">
   Silver-Russell syndrome 5
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05830">
   Skeletal dysplasia, mild, with joint laxity and advanced bone age
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05855">
   Sorbitol dehydrogenase deficiency with peripheral neuropathy
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05828">
   Tremor, hereditary essential 6
  </a>
 </li>
</ul>
<p>
 Modified diseases:
</p>
<ul>
 <li>
  Abnormal thyroid hormone metabolism -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00015">
   Thyroid hormone metabolism, abnormal
  </a>
 </li>
 <li>
  Autoinflammation, antibody deficiency, and immune dysregulation PLCG2-associated -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03601">
   Autoinflammation, antibody deficiency, and immune dysregulation
  </a>
 </li>
 <li>
  Cardiac valvular dysplasia X-linked -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02915">
   Cardiac valvular dysplasia, X-linked
  </a>
 </li>
 <li>
  Cataract 46, juvenile-onset -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04739">
   Cataract 46, juvenile-onset, with or without arrhythmic cardiomyopathy
  </a>
 </li>
 <li>
  Contractures, pterygia, and variable skeletal fusions syndrome 1A -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05625">
   Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A
  </a>
 </li>
 <li>
  Contractures, pterygia, and variable skeletal fusions syndrome 1B -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05594">
   Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1B
  </a>
 </li>
 <li>
  Cornelia de Lange syndrome 3 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01432">
   Cornelia de Lange syndrome 3 with or without midline brain defects
  </a>
 </li>
 <li>
  Cornelia de Lange syndrome 4 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03491">
   Cornelia de Lange syndrome 4 with or without midline brain defects
  </a>
 </li>
 <li>
  Crisponi/Cold-induced sweating syndrome 3 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04779">
   Perching syndrome
  </a>
 </li>
 <li>
  D-lactic aciduria -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05545">
   D-lactic aciduria with gout
  </a>
 </li>
 <li>
  Deafness, X-linked, 5 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04610">
   Deafness, X-linked, 5, with peripheral neuropathy
  </a>
 </li>
 <li>
  Diabetes mellitus, permanent neonatal -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02152">
   Diabetes mellitus, permanent neonatal 1
  </a>
 </li>
 <li>
  Dyskinesia, seizures, and intellectual developmental disorder -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04854">
   Neurodevelopmental disorder with hypotonia, impaired expressive language, and with or without seizures
  </a>
 </li>
 <li>
  Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04879">
   Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy 1
  </a>
 </li>
 <li>
  Epimerase-deficiency galactosemia -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01534">
   Galactosemia 3
  </a>
 </li>
 <li>
  Familial adenomatous polyposis -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01547">
   Familial adenomatous polyposis 1
  </a>
 </li>
 <li>
  Familial hibernian fever -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00491">
   Periodic fever, familial, autosomal dominant
  </a>
 </li>
 <li>
  Familial hypercholesterolemia -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01577">
   Hypercholesterolemia, familial, 1
  </a>
 </li>
 <li>
  Familial ligand-defective apolipoprotein B-100 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01591">
   Hypercholesterolemia, familial, 2
  </a>
 </li>
 <li>
  Galactosemia -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01642">
   Galactosemia 1
  </a>
 </li>
 <li>
  Galactosemia II -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01643">
   Galactosemia 2
  </a>
 </li>
 <li>
  Glycosylphosphatidylinositol biosynthesis defect 21 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05663">
   Neurodevelopmental disorder with brain anomalies, seizures, and scoliosis
  </a>
 </li>
 <li>
  Glycosylphosphatidylinositol deficiency -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01677">
   Glycosylphosphatidylinositol biosynthesis defect 1
  </a>
 </li>
 <li>
  Growth restriction, severe, with distinctive facies -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04494">
   Silver-Russell syndrome 3
  </a>
 </li>
 <li>
  Hereditary desmoid disease -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01711">
   Desmoid disease, hereditary
  </a>
 </li>
 <li>
  High density lipoprotein deficiency 1 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01742">
   Tangier disease
  </a>
 </li>
 <li>
  High density lipoprotein deficiency 2 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01743">
   Hypoalphalipoproteinemia, primary, 1
  </a>
 </li>
 <li>
  Hypercholesterolemia, autosomal dominant, 3 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01578">
   Hypercholesterolemia, familial, 3
  </a>
 </li>
 <li>
  Hypercholesterolemia, autosomal recessive -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01242">
   Hypercholesterolemia, familial, 4
  </a>
 </li>
 <li>
  Hypoparathyroidism, familial isolated -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01590">
   Hypoparathyroidism, familial isolated, 1
  </a>
 </li>
 <li>
  Immunodeficiency 57 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05328">
   Immunodeficiency 57 with autoinflammation
  </a>
 </li>
 <li>
  Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04996">
   Jansen-de Vries syndrome
  </a>
 </li>
 <li>
  IRAK4 deficiency -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01831">
   Immunodeficiency 67
  </a>
 </li>
 <li>
  Keratitis-ichthyosis-deafness syndrome -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00624">
   Keratitis-ichthyosis-deafness syndrome, autosomal dominant
  </a>
 </li>
 <li>
  Knuckle pads, leukonychia, and sensorineural deafness -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00172">
   Bart-Pumphrey syndrome
  </a>
 </li>
 <li>
  Lujan-Fryns syndrome -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01917">
   Intellectual developmental disorder, X-linked, syndromic, Lujan-Fryns type
  </a>
 </li>
 <li>
  Melorheostosis -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01963">
   Melorheostosis, isolated
  </a>
 </li>
 <li>
  Mental retardation, autosomal dominant 9 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03252">
   NESCAV syndrome
  </a>
 </li>
 <li>
  Mental retardation, autosomal dominant 24 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04122">
   Vulto-van Silfout-de Vries syndrome
  </a>
 </li>
 <li>
  Mental retardation, autosomal dominant 25 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04125">
   Xia-Gibbs syndrome
  </a>
 </li>
 <li>
  Mental retardation, autosomal dominant 27 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04132">
   Coffin-Siris syndrome 9
  </a>
 </li>
 <li>
  Mental retardation, autosomal dominant 32 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04351">
   Arboleda-Tham syndrome
  </a>
 </li>
 <li>
  Mental retardation, autosomal dominant 44 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04798">
   Intellectual developmental disorder, autosomal dominant 44, with microcephaly
  </a>
 </li>
 <li>
  Mental retardation, autosomal dominant 49 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05132">
   Clark-Baraitser syndrome
  </a>
 </li>
 <li>
  Mental retardation, X-linked, syndromic, ZDHHC9-related -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02508">
   Intellectual developmental disorder, X-linked, syndromic, Raymond type
  </a>
 </li>
 <li>
  Mental retardation, X-linked 102 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04512">
   Intellectual developmental disorder, X-linked, syndromic, Snijders Blok type
  </a>
 </li>
 <li>
  Microcephaly, seizures, spasticity, and brain calcifications -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05123">
   Diencephalic-mesencephalic junction dysplasia syndrome 1
  </a>
 </li>
 <li>
  MYD88 deficiency -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02015">
   Immunodeficiency 68
  </a>
 </li>
 <li>
  Myopathy, proximal, and ophthalmoplegia -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01816">
   Myopathy, proximal, with ophthalmoplegia
  </a>
 </li>
 <li>
  Nail disorder, non-syndromic congenital, 10 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03199">
   Nail disorder, non-syndromic congenital, 1
  </a>
 </li>
 <li>
  Neurodevelopmental disorder, X-linked, with craniofacial abnormalities -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05502">
   Mullegama-Klein-Martinez syndrome
  </a>
 </li>
 <li>
  Neurodevelopmental disorder with macrocephaly and with or without seizures -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05723">
   Intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures
  </a>
 </li>
 <li>
  Neuropathy, hereditary motor and sensory, 6B -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04538">
   Neuropathy, hereditary motor and sensory, 6B, with optic atrophy
  </a>
 </li>
 <li>
  Recessive hereditary megaloblastic anemia 1 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02246">
   Imerslund-Grasbeck syndrome 1
  </a>
 </li>
 <li>
  Robinow syndrome autosomal recessive -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02247">
   Robinow syndrome, autosomal recessive 1
  </a>
 </li>
 <li>
  Rothmund-Thomson syndrome -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02274">
   Rothmund-Thomson syndrome 2
  </a>
 </li>
 <li>
  Silver-Russell syndrome -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02493">
   Silver-Russell syndrome 1
  </a>
 </li>
 <li>
  Spastic paraplegia 30, autosomal recessive -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03243">
   Spastic paraplegia 30
  </a>
 </li>
 <li>
  Thrombotic thrombocytopenic purpura congenital -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01421">
   Thrombotic thrombocytopenic purpura, hereditary
  </a>
 </li>
</ul>
<p>
 Deleted diseases
</p>
<ul>
 <li>
  Arthrogryposis, distal, 8
 </li>
 <li>
  Ectodermal dysplasia, anhidrotic, with immunodeficiency, osteopetrosis and lymphedema
 </li>
 <li>
  Immunodeficiency, NEMO-related, without anhidrotic ectodermal dysplasia
 </li>
 <li>
  Recurrent isolated invasive pneumococcal disease 1
 </li>
 <li>
  Recurrent isolated invasive pneumococcal disease 2
 </li>
</ul>
<h3 id="Changes_to_the__a_href___docs_ptmlist__controlled_vocabulary_for_PTMs__a_">
 Changes to the
 <a href="http://www.uniprot.org/docs/ptmlist">
  controlled vocabulary for PTMs
 </a>
</h3>
<p>
 New terms for the feature key 'Glycosylation' ('CARBOHYD' in the flat file):
</p>
<ul>
 <li>
  O-alpha-linked (GlcNAc) threonine
 </li>
 <li>
  O-linked (Glc) threonine
 </li>
</ul>
<h3 id="Changes_to__a_href___docs_keywlist__keywords__a_">
 Changes to
 <a href="http://www.uniprot.org/docs/keywlist">
  keywords
 </a>
</h3>
<p>
 New keyword:
</p>
<ul>
 <li>
  <a href="http://www.uniprot.org/keywords/KW-1282">
   Carboxysome
  </a>
 </li>
</ul>